{"id":"W7002268079","doi":"","title":"$82.12 Million in Sales Expected for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) This Quarter","year":2021,"lang":"en","type":"other","venue":"","topic":"Legal Cases and Commentary","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Consumption (sociology); Work (physics); Revenue","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009279546,0.0005887306,0.0003690147,0.001365941,0.002953426,0.003900204,0.0009823083,0.006646425,0.3077765],"category_scores_gemma":[0.004611034,0.0003394437,0.0004641469,0.0006999763,0.0009475541,0.001179362,0.001566745,0.003699787,0.1882654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003517285,"about_ca_system_score_gemma":0.004331985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0410339,"about_ca_topic_score_gemma":0.07735197,"domain_scores_codex":[0.9990093,0.00009434553,0.00004121078,0.00009251182,0.0005565257,0.0002061435],"domain_scores_gemma":[0.9980543,0.000409327,0.0001139822,0.000066192,0.0008925369,0.0004636724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001090978,0.00001202279,0.00007517528,0.00001730444,8.559167e-7,0.00003061748,0.00001190088,0.00001111069,0.00005213546,0.001809454,0.9929397,0.00502867],"study_design_scores_gemma":[0.00001456352,0.00001048122,0.0008633949,0.00008421433,0.000002186995,0.00003512006,0.00008156092,0.00005419291,0.00006494418,0.0006020213,0.9981817,0.000005651767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0006785787,0.001123765,0.0001148201,0.04402047,0.004519654,0.00007414553,0.001875942,0.0002319267,0.9473607],"genre_scores_gemma":[0.002830761,0.000701025,0.0001032711,0.02554164,0.001754655,0.00005666717,0.0007404917,0.00007747094,0.968194],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.6922235,"threshold_uncertainty_score":0.9873728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04022520104538017,"score_gpt":0.3367334672410688,"score_spread":0.2965082661956886,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}